Value-based pricing of drugs in the UK

Lancet. 2007 Apr 28;369(9571):1415-1416. doi: 10.1016/S0140-6736(07)60648-5.

Authors

David J Webb¹, Andrew Walker²

Affiliations

¹ Clinical Pharmacology Unit, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK. Electronic address: [email protected].
² Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.

PMID: 17467498
DOI: 10.1016/S0140-6736(07)60648-5

No abstract available

MeSH terms

Cost-Benefit Analysis*
Drug Industry / economics*
Health Care Reform / economics
Humans
National Health Programs / economics*
Pharmaceutical Preparations / economics*
Quality-Adjusted Life Years*
United Kingdom

Substances

Pharmaceutical Preparations